Canaccord Genuity maintains a 'Hold' on AngioDynamics (NASDAQ: ANGO), PT lowered to $15.

Canaccord analyst, Jason R. Mills, said, "ANGO ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE